These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 2380132

  • 1. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK, Turakhia DP, Sharma SS, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Feb; 38(2):136-40. PubMed ID: 2380132
    [Abstract] [Full Text] [Related]

  • 2. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ, Brun D, Gagné C, Moorjani S, Bielman P, Julien P.
    Can J Cardiol; 1991 Feb; 7(1):27-33. PubMed ID: 2025787
    [Abstract] [Full Text] [Related]

  • 3. Gemfibrozil also corrects dyslipidemia in postmenopausal women and smokers.
    Koskinen P, Kovanen PT, Tuomilehto J, Manninen V.
    Arch Intern Med; 1992 Jan; 152(1):90-6. PubMed ID: 1728934
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR.
    Drugs Exp Clin Res; 1994 Jan; 20(3):109-13. PubMed ID: 7956717
    [Abstract] [Full Text] [Related]

  • 6. Gemfibrozil in dyslipidaemia.
    Kundu SC, Roxy S, Batabyal SK.
    J Assoc Physicians India; 1990 Feb; 38(2):156-9. PubMed ID: 2199426
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores EA, González-Valdez H, Gómez Pérez FJ.
    Metabolism; 2001 Jun; 50(6):729-33. PubMed ID: 11398153
    [Abstract] [Full Text] [Related]

  • 10. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil.
    Sommariva D, Branchi A, Pini C, Scandiani L, Orlandi S, Fasoli A.
    Int J Clin Pharmacol Res; 1988 Jun; 8(5):383-92. PubMed ID: 3068163
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial.
    McCrindle BW, Ose L, Marais AD.
    J Pediatr; 2003 Jul; 143(1):74-80. PubMed ID: 12915827
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases.
    Varthakavi P, Turakhia DP, Sharma S, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Nov; 38(11):860-2. PubMed ID: 2079473
    [Abstract] [Full Text] [Related]

  • 17. Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study.
    Insua A, Massari F, Rodríguez Moncalvo JJ, Rubén Zanchetta J, Insua AM.
    Endocr Pract; 2002 Nov; 8(2):96-101. PubMed ID: 11942772
    [Abstract] [Full Text] [Related]

  • 18. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF, McGladdery SH, McNeely MJ, Austin MA, Motulsky AG, Brunzell JD.
    Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1289-94. PubMed ID: 12750118
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of pravastatin for hyperlipidemia in patients with type 2 diabetes mellitus.
    Tawata M, Miwa I, Tsuchiya K, Ozawa M, Shindo H, Wakasugi M, Onaya T.
    Arzneimittelforschung; 1995 Jun 01; 45(6):704-8. PubMed ID: 7646575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.